Literature DB >> 17409158

Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.

Anna Ekman1, Kati Hokynar, Laura Kakkola, Kalle Kantola, Lea Hedman, Heidi Bondén, Matthias Gessner, Claudia Aberham, Päivi Norja, Simo Miettinen, Klaus Hedman, Maria Söderlund-Venermo.   

Abstract

The human parvovirus B19 is now divided into three genotypes: type 1 (prototype), type 2 (A6- and LaLi-like), and type 3 (V9-like). In overall DNA sequence, the three virus types differ by approximately 10%. The most striking DNA dissimilarity, of >20%, is observed within the p6 promoter region. Because of the scarcity of data on the biological activities and pathogenetic potentials of virus types 2 and 3, we examined the functional characteristics of these virus types. We found the activities of the three p6 promoters to be of equal strength and to be most active in B19-permissive cells. Virus type 2 capsid protein VP2, alone or together with VP1, was expressed with the baculovirus system and was shown to assemble into icosahedral parvovirus-like particles, which were reactive in the hemagglutination assay. Furthermore, sera containing DNA of any of the three B19 types were shown to hemagglutinate. The infectivities of these sera were examined in two B19-permissive cell lines. Reverse transcription-PCR revealed synthesis of spliced B19 mRNAs, and immunofluorescence verified the production of NS and VP proteins in the infected cells. All three genotypes showed similar functional characteristics in all experiments performed, showing that the three virus types indeed belong to the same species, i.e., human parvovirus B19. Additionally, the antibody activity in sera from B19 type 1- or type 2-infected subjects (long-term immunity) was examined with homo- and heterologous virus-like particles. Cross-reactivity of 100% was observed, indicating that the two B19 genotypes comprise a single serotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409158      PMCID: PMC1933287          DOI: 10.1128/JVI.02713-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.

Authors:  Martin Enders; Gunnar Schalasta; Carola Baisch; Andrea Weidner; Laura Pukkila; Leena Kaikkonen; Hilkka Lankinen; Lea Hedman; Maria Söderlund-Venermo; Klaus Hedman
Journal:  J Clin Virol       Date:  2005-12-05       Impact factor: 3.168

2.  Human parvovirus B19 infection of monocytic cell line U937 and antibody-dependent enhancement.

Authors:  Yasuhiko Munakata; Ichiro Kato; Takako Saito; Takao Kodera; Keiko Kumura Ishii; Takeshi Sasaki
Journal:  Virology       Date:  2005-10-24       Impact factor: 3.616

3.  Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein.

Authors:  Jun Lu; Ning Zhi; Susan Wong; Kevin E Brown
Journal:  J Infect Dis       Date:  2006-01-19       Impact factor: 5.226

4.  Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms.

Authors:  Sabri Sanabani; Walter Kleine Neto; Juliana Pereira; Ester Cerdeira Sabino
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic.

Authors:  Armen Parsyan; Shane Kerr; Shirley Owusu-Ofori; Gordon Elliott; Jean-Pierre Allain
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

6.  A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity.

Authors:  M Momoeda; S Wong; M Kawase; N S Young; S Kajigaya
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Phylogenetic evidence for the rapid evolution of human B19 erythrovirus.

Authors:  Laura A Shackelton; Edward C Holmes
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  A novel protein encoded by small RNAs of parvovirus B19.

Authors:  W Luo; C R Astell
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

9.  Identification and characterization of a family of 11-kDa proteins encoded by the human parvovirus B19.

Authors:  J St Amand; C R Astell
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

10.  Novel parvovirus and related variant in human plasma.

Authors:  Jacqueline F Fryer; Amit Kapoor; Philip D Minor; Eric Delwart; Sally A Baylis
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

View more
  21 in total

1.  Human B19 erythrovirus in vitro replication: what's new?

Authors:  Sylvie Pillet; Serge Fichelson; Frédéric Morinet; Neal S Young; Ning Zhi; Susan Wong
Journal:  J Virol       Date:  2008-09       Impact factor: 5.103

2.  Molecular characterization of human parvovirus B19 genotypes 2 and 3.

Authors:  Zhaojun Chen; Wuxiang Guan; Fang Cheng; Aaron Yun Chen; Jianming Qiu
Journal:  Virology       Date:  2009-09-15       Impact factor: 3.616

3.  Parvovirus B19 - Revised.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

4.  Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay.

Authors:  Francesca Bonvicini; Elisabetta Manaresi; Gloria Bua; Simona Venturoli; Giorgio Gallinella
Journal:  J Clin Microbiol       Date:  2013-09-04       Impact factor: 5.948

5.  Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples.

Authors:  Mei-Ying W Yu; Harvey J Alter; Maria Luisa A Virata-Theimer; Yansheng Geng; Li Ma; Cathy A Schechterly; Camilla A Colvin; Naomi L C Luban
Journal:  Transfusion       Date:  2010-02-12       Impact factor: 3.157

6.  Molecular phenotypes of human parvovirus B19 in patients with myocarditis.

Authors:  C-Thomas Bock; Anja Düchting; Friederike Utta; Eva Brunner; Bui Tien Sy; Karin Klingel; Florian Lang; Meinrad Gawaz; Stephan B Felix; Reinhard Kandolf
Journal:  World J Cardiol       Date:  2014-04-26

7.  Genetic variants of human parvovirus B19 in South Africa: cocirculation of three genotypes and identification of a novel subtype of genotype 1.

Authors:  Craig Corcoran; Diana Hardie; Jane Yeats; Heidi Smuts
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

8.  Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections.

Authors:  Päivi Norja; Anna Maria Eis-Hübinger; Maria Söderlund-Venermo; Klaus Hedman; Peter Simmonds
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

9.  The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus.

Authors:  Wuxiang Guan; Susan Wong; Ning Zhi; Jianming Qiu
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

10.  Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children, Finland.

Authors:  Maria Söderlund-Venermo; Anne Lahtinen; Tuomas Jartti; Lea Hedman; Kaisa Kemppainen; Pasi Lehtinen; Tobias Allander; Olli Ruuskanen; Klaus Hedman
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.